After Concorde.
作者信息
Gazzard B G
出版信息
BMJ. 1993 Apr 17;306(6884):1016-7. doi: 10.1136/bmj.306.6884.1016.
Abstract
摘要
相似文献
1
After Concorde.协和式飞机之后。
BMJ. 1993 Apr 17;306(6884):1016-7. doi: 10.1136/bmj.306.6884.1016.
2
The Concorde zidovudine trial and antiretroviral strategies for asymptomatic patients.协和齐多夫定试验与无症状患者的抗逆转录病毒策略。
J Am Board Fam Pract. 1993 Nov-Dec;6(6):604-6.
3
Concorde remains aloft.协和式飞机仍在空中。
Lancet. 1989 Oct 28;2(8670):1017-8.
4
Trends in zidovudine prescription since 1987 in AIDS-free HIV-positive French patients attending university hospitals.1987年以来，在大学医院就诊的未患艾滋病的HIV阳性法国患者中齐多夫定的处方趋势。
AIDS. 1992 Nov;6(11):1405-6. doi: 10.1097/00002030-199211000-00032.
5
The Concorde trial.协和式飞机试验。
Lancet. 1993 May 15;341(8855):1276.
6
7
8
NIH panel loosens zidovudine guidelines.美国国立卫生研究院小组放宽齐多夫定指导方针。
Lancet. 1993 Jul 10;342(8863):104-5. doi: 10.1016/0140-6736(93)91295-w.
9
Concorde trial of immediate versus deferred zidovudine.
Lancet. 1994 May 28;343(8909):1357; author reply 1358.
10
Zidovudine therapy in combination with intravenous immunoglobulin in HIV infected children.齐多夫定疗法联合静脉注射免疫球蛋白用于HIV感染儿童的治疗
Scott Med J. 1992 Oct;37(5):138-41. doi: 10.1177/003693309203700503.
引用本文的文献
1
Will we ever know when to treat HIV infection?
BMJ. 1996 Sep 7;313(7057):608-10. doi: 10.1136/bmj.313.7057.608.
2
Zidovudine unproved in AIDS dementia.齐多夫定对艾滋病痴呆症疗效未经证实。
BMJ. 1993 Jun 5;306(6891):1543-4. doi: 10.1136/bmj.306.6891.1543-c.
3
Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.齐多夫定。其药效学和药代动力学特性以及治疗效果的最新情况。
Drugs. 1993 Sep;46(3):515-578. doi: 10.2165/00003495-199346030-00010.
本文引用的文献
1
Doubt cast on zidovudine's use in delaying AIDS.齐多夫定用于延缓艾滋病病情的作用受到质疑。
BMJ. 1993 Apr 10;306(6883):949-50.
2
HIV is active even in latency, say scientists.科学家称，即使处于潜伏期，艾滋病毒也具有活性。
BMJ. 1993 Apr 10;306(6883):949. doi: 10.1136/bmj.306.6883.949.
3
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.在疾病的临床潜伏期，HIV感染在淋巴组织中活跃且呈进行性发展。
Nature. 1993 Mar 25;362(6418):355-8. doi: 10.1038/362355a0.
4
Preliminary analysis of the Concorde trial. Concorde Coordinating Committee.协和试验的初步分析。协和协调委员会。
Lancet. 1993 Apr 3;341(8849):889-90. doi: 10.1016/0140-6736(93)93096-j.
5
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.叠氮胸苷（AZT）治疗艾滋病及艾滋病相关综合征患者的疗效。一项双盲、安慰剂对照试验。
N Engl J Med. 1987 Jul 23;317(4):185-91. doi: 10.1056/NEJM198707233170401.
6
Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.齐多夫定（AZT）治疗艾滋病及艾滋病相关综合征患者的神经心理学转归
N Engl J Med. 1988 Dec 15;319(24):1573-8. doi: 10.1056/NEJM198812153192404.
7
Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.人类免疫缺陷病毒变异体的生物学特性与艾滋病风险及艾滋病死亡率之间的关联。
Lancet. 1989 May 6;1(8645):983-5. doi: 10.1016/s0140-6736(89)92628-7.
8
Effect of stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus.
J Acquir Immune Defic Syndr (1988). 1990;3(8):743-6.
9
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.齐多夫定（AZT）治疗轻度症状的1型人类免疫缺陷病毒（HIV）感染患者的安全性和有效性。一项双盲、安慰剂对照试验。艾滋病临床试验组。
Ann Intern Med. 1990 May 15;112(10):727-37. doi: 10.7326/0003-4819-112-10-727.
10
Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.齐多夫定用于无症状人类免疫缺陷病毒感染。对每立方毫米CD4阳性细胞少于500个的患者进行的对照试验。美国国立过敏与传染病研究所艾滋病临床试验组。
N Engl J Med. 1990 Apr 5;322(14):941-9. doi: 10.1056/NEJM199004053221401.
Zotero 插件